CME Says Bitcoin Index Options Fall Under CFTC, Challenges SEC Approval
CME Group challenged the SEC’s approval of Nasdaq PHLX cash-settled Bitcoin index options, arguing the product falls under CFTC jurisdiction because Bitcoin is a commodity, not a security. The SEC accepted CME’s petition July 29, stayed approval, and seeks comments through Aug. 24. Nasdaq plans to list under ticker QBTC, pending CFTC exemptive relief.
How this was made

The 30-second read
Why it matters
The SEC’s temporary stay and public-comment window create a decision timeline that can affect exchange readiness, clearing/operational planning, and competitive dynamics among crypto-derivatives venues.
Market read
A live SEC review over crypto options jurisdiction can shift expectations for product approvals and competitive positioning in US crypto derivatives.
What to watch
The product’s cash-settled structure and index methodology may be viewed as closer to commodity index derivatives than spot-ETF securities, affecting how regulators draw the line.
Background
CME and Nasdaq are disputing whether cash-settled Bitcoin index options should fall under SEC rules (securities) or CFTC oversight (commodities).
Ticker impact
CME challenged the SEC’s conditional approval of Nasdaq’s cash-settled Bitcoin index options, arguing CFTC has exclusive jurisdiction over Bitcoin as a commodity.
Near-term volatility risk for CME tied to evolving SEC/CFTC stance and any knock-on effects to crypto-derivatives listings.
The article is about a pending SEC review and temporary stay, which can change timelines and precedent for crypto options oversight.
Market effects
Sets precedent risk for how crypto-linked options are classified and supervised between SEC and CFTC, influencing exchange product pipelines.
Primarily US regulatory process, but could affect global crypto-derivatives market structure and listing strategies.
Jurisdictional clarity (or lack of it) can influence international exchange offerings of crypto index options and hedging products.
Counterpoint
SEC may ultimately uphold its approval, limiting the practical impact of CME’s jurisdictional arguments and allowing Nasdaq’s product to proceed.
Key entities
- companyCME Group
Challenged the SEC’s conditional approval of Nasdaq PHLX cash-settled Bitcoin index options, arguing exclusive CFTC jurisdiction.
- companyNasdaq
Pursuing the cash-settled Bitcoin index options product on Nasdaq PHLX, planning to list under ticker QBTC.
- regulatorSEC
Accepted CME’s petition for review, temporarily stayed approval, and is taking public comment through Aug. 24.
- regulatorCFTC
CME argues it has exclusive supervisory authority over Bitcoin-based derivatives because Bitcoin is a commodity.
- venueNasdaq PHLX
Exchange venue where the cash-settled Bitcoin index options listing is being pursued.


